繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Indivior Says BARDA Makes 1st Order of Opioid Overdose Reversal Nasal Spray

2024-08-26 23:14

11:14 AM EDT, 08/26/2024 (MT Newswires) -- Indivior (INDV) said Monday that the Biomedical Advanced Research and Development Authority or BARDA has made its first order of Opvee, a nalmefene opioid overdose reversal nasal spray.

The company said $8.7 million in Project BioShield designated funding for the initial procurement will be used by BARDA, which is part of the Administration for Strategic Preparedness and Response within the US Department of Health and Human Services.

Over the next nine years, BARDA can buy additional Opvee annually under Invidior vendor-managed inventory, the company said.

Shares of Indivior were up 1.9% in recent Monday trading.

Price: 12.53, Change: +0.23, Percent Change: +1.87

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。